Nidhi Kaushal - Concepedia

Author

Nidhi Kaushal

West Virginia University

Also Known As

IJAR, N Kaushal, Nidhi Kaushal

Publications

710

Citations

H-Index

Concepts

All Affiliations

West Virginia University University of Mississippi Takeda (United States)

About

Nidhi Kaushal is an author at West Virginia University specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	245
2	Pharmacology	7	7	245
3	Neuroscience	4	4	129
4	Social Sciences	3	3	105
5	Biochemistry	2	2	79

Nidhi Kaushal

Publications

488

Citations

H-Index

Page 1

	Year	Citations
Conversion of a Highly Selective Sigma-1 Receptor–Ligand to Sigma-2 Receptor Preferring Ligands with Anticocaine Activity Christophe Mésangeau, Sanju Narayanan, Andrea M. Green, Journal of Medicinal Chemistry Molecular PharmacologyDrug TargetSigma-1 ReceptorsSelective Sigma-2 LigandBiochemistry	2008	57
Role of Sigma Receptors in Methamphetamine-Induced Neurotoxicity Nidhi Kaushal, Rae R. Matsumoto Current Neuropharmacology Psychotropic MedicationPsychopharmacologyPharmacotherapyExperimental PharmacologySocial Sciences	2011	48
Epidemiology of Congenital Rubella Syndrome (CRS) in India, 2016-18, based on data from sentinel surveillance Manoj Murhekar, Sanjay Verma, Kuldeep Singh, PLoS neglected tropical diseases	2020	48
First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson’s Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate Huikai Sun, Holger Monenschein, Hans H. Schiffer, Journal of Medicinal Chemistry	2021	43
Synthesis and Pharmacological Evaluation of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a Cocaine Antagonist, in Rodents Nidhi Kaushal, Matthew J. Robson, Harsha Vinnakota, The AAPS Journal Molecular PharmacologyPsychoactive DrugPharmacological StudyMedicineCocaine Antagonist	2011	37
Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease Nicola Brice, Hans H. Schiffer, Holger Monenschein, Journal of Pharmacology and Experimental Therapeutics	2021	36
Discovery of TAK-041: a Potent and Selective GPR139 Agonist Explored for the Treatment of Negative Symptoms Associated with Schizophrenia H Reichard, Hans H. Schiffer, Holger Monenschein, Journal of Medicinal Chemistry	2021	35
CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice Nidhi Kaushal, Michael J. Seminerio, Jamaluddin Shaikh, Neuropharmacology Psychoactive DrugMedicineNeurotoxic EffectsPsychopharmacologyNeuropharmacology	2011	33
A Novel Substituted Piperazine, CM156, Attenuates the Stimulant and Toxic Effects of Cocaine in Mice Yan‐Tong Xu, Nidhi Kaushal, Jamaluddin Shaikh, Journal of Pharmacology and Experimental Therapeutics	2010	33
Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo Nidhi Kaushal, Michael J. Seminerio, Matthew J. Robson, European Neuropsychopharmacology Molecular PharmacologyMedicineReceptor LigandNeuropharmacologyExperimental Pharmacology	2012	24

Page 1